Physician profile
Sonal Bhalla
NPI 1710265350
$1,095.61
in general payments reported to CMS, 2019-2025
14 companies · $25.89 in 2025
The $25.89 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $31.14 · 2021: $143 · 2022: $20.08 · 2023: $196 · 2025: $25.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $246.69 | 2019-2021 | |
| Amgen INC. | $203.59 | 2019-2025 | Uplizna |
| Ucb, INC. | $165.24 | 2021-2023 | Cimzia |
| Sunovion Pharmaceuticals INC. | $124.08 | 2019 | |
| Bioventus LLC | $115.00 | 2019 | |
| Abbvie INC. | $92.46 | 2019 | |
| Biogen, INC. | $28.82 | 2023 | Vumerity |
| Teva Pharmaceuticals USA, INC. | $24.49 | 2019 | |
| Livanova USA, INC. | $19.97 | 2019 | |
| Tanabe Pharma America, INC. | $16.08 | 2019 | |
| Avanir Pharmaceuticals, INC. | $15.66 | 2020 | |
| Ge Healthcare | $15.48 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.55 | 2023 | Cyltezo |
| Vertical Pharmaceuticals, LLC | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonal Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.